arrow
Z

Ziling Li

Chinese Academy of Sciences
H指数:13
被引数:582

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 study

德谷胰岛素/门冬胰岛素生物类似药B01711相较于原研德谷胰岛素/门冬胰岛素在经基础或预混胰岛素治疗控制不佳的2型糖尿病中国患者中的有效性与安全性:一项多中心、随机、开放标签、III期研究

2025-11-210
OAAI
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial
2023-10-090
OA